News Daily News NOACs Significantly Curb Risk of VTE in Cancer Patients L.A. McKeown December 06, 2018
News Daily News Quality of Anticoagulation Therapy Lower in Black Patients With A-fib Todd Neale December 03, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Daily News NOACs Particularly Beneficial for Women With A-fib, Study Suggests Todd Neale July 11, 2018
News Daily News NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin L.A. McKeown May 16, 2018
News Conference News HRS 2018 NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low Todd Neale May 11, 2018
News Daily News Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval Michael O'Riordan May 01, 2018
Presentation ACC 2018 Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants Presenter: Steve Deitelzweig March 12, 2018
News Conference News ACC 2018 ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More Shelley Wood March 12, 2018
News Daily News Research Series Sheds Light on Questions Surrounding Stroke Risk in Women L.A. McKeown February 09, 2018
News Conference News ISC 2018 COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke Todd Neale January 25, 2018
News Daily News NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin L.A. McKeown January 02, 2018